PerkinElmer profit tops estimates on strong sales of newborn screening tests

Jan 29 (Reuters) - Scientific instruments maker PerkinElmer Inc reported better-than-expected quarterly adjusted revenue and profit, helped by strong sales of its newborn diagnostic screening tests in developing markets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.